Moderna wins second product approval with RSV vaccine
Moderna’s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA vaccine has...
‘We’re on good terms’: My wife and I are getting divorced, but want to keep our 3% mortgage rate. What could go wrong?
“Given that she’s not planning to buy a house, it should not impact her by keeping her on the loans and the deed.”
What’s worth streaming in June 2024: ‘House of the Dragon,’ ‘The Bear’ and much more
‘Bridgerton,’ ‘The Boys,’ ‘Hit Man’ and ‘The Acolyte’ co-headline a blockbuster month. Here’s how to spend your streaming money wisely.
Trump raises $35 million after guilty verdict as donors crash website
Donald Trump’s 2024 presidential campaign said it’s enjoying record success with fundraising after a jury found him guilty on all 34 counts in his Manhattan hush-money case.
Medicare drug premiums are going up — ‘dramatically’ — just in time for open enrollment this fall
Expect Medicare Part D premiums to be “much, much higher,” warns a senior health insurance executive
Aston Martin gets a boost from Formula 1 and new high-performance models
Aston Martin has overhauled manufacturing, shored up its financials and is now launching a fleet of new products defined by high-performance.
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
The company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
Trump’s guilty verdicts make 34 cases for gold
If you want to understand why gold is more valuable than ever just ask Donald Trump.